OSPREY THERAPEUTICS

Class [5]
Pharmaceutical Products

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases and disorders; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and disorders; pharmaceutical preparations for the prevention and treatment of endocrinological diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases or disorders; pharmaceutical preparations for the prevention and treatment of liver diseases or disorders pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in gynecology and urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of genetic diseases and disorders; pharmaceutical preparations and human therapeutic preparations for treating and preventing amyloidosis, genetic diseases, disorders and conditions, and protein diseases, disorders and conditions; pharmaceutical preparations and human therapeutic preparations for treating neuropathy, neurological dysfunction, and damage to nerves, tissue, organs, intestinal tract, or bone marrow; injectable drugs for reducing production of transthyretin; antisense drugs.